By Administrator at 29 Sep 2015
For three decades, researchers have been trying to develop a drug that might inhibit the most commonly mutated oncogene in human cancers.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
